MedWatch Technologies, Inc. — SEC Form D Filing

MedWatch Technologies, Inc. filed an SEC Form D on March 6, 2026, reporting $17.55M raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
March 6, 2026
Amount reported
$17.55M
Round stage
Pre-Seed
Industry
Health Technology
Website
https://medwatchtech.com/

What the company does

Securities: Equity, Debt. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Many individuals struggle with managing their metabolic health effectively.

Solution

The company provides a non-invasive health management platform that utilizes biosensing technology and AI coaching to help users proactively manage their metabolic health.

Why now

There is a growing awareness and focus on health management, particularly in metabolic health, driving the need for innovative solutions.

Verdict

Investors said yes at that moment because MetWatch Technologies offered a relevant solution to a growing consumer concern in metabolic health, not because competitors were clearly defined. They were betting on an emerging demand for personalized health solutions coupled with an innovative use of biosensing and AI, which might have limited upside considering the risk of market saturation and the challenge of achieving consumer adoption in the wellness space.

Source: SEC EDGAR Form D filing